Viewing nowCombinationDunav 30/2.5 mg (Pimasartan Potassium, Esamlodipine)
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.

MFDS item code 202204666 · Approved 2022.12.27 · Insurance code 649105670
Treatment of essential hypertension not controlled with fimasartan monotherapy
Pimasartan potassium is used in cases where blood pressure control is difficult in patients with essential hypertension, helping to effectively lower blood pressure. This medication is used to reduce the risk of cardiovascular diseases and improve health by properly managing blood pressure.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus and newborns if taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. It should not be used in patients with allergies to the active ingredients or similar substances, those who are pregnant or breastfeeding, patients on dialysis, those with moderate to severe liver impairment, patients with biliary obstruction, certain kidney disease patients, patients with genetic lactose intolerance, patients with severe aortic stenosis, and patients in shock. Caution is advised for patients with low blood volume or salt, patients with impaired renal function, patients with renal artery hypertension, patients with aortic and mitral stenosis, patients with primary hyperaldosteronism, patients with severe hypotension, elderly patients, and those with hypersensitivity to certain pigments. While taking this medication, side effects such as dizziness, headache, facial swelling, urinary disorders, insomnia, and flushing may occur, and there is a rare risk of serious kidney issues or blood pressure drop. Patients with hypotension or electrolyte imbalance should be particularly cautious when starting or increasing the dosage; if blood pressure drops too low, they should be laid down and given fluid treatment if necessary. This medication can increase the risk of hyperkalemia, so patients with heart failure or impaired kidney function should have their serum potassium levels checked regularly. If combined with other antihypertensives, there is a risk of excessive blood pressure reduction, so caution is needed, and if the antihypertensive effect is severe, consult a doctor immediately. Dizziness or drowsiness may occur when driving or operating machinery, so patients should be careful. Women who are pregnant or breastfeeding are advised to avoid taking this medication, and if necessary, should consult with a doctor to take appropriate measures. Safety and efficacy have not been established in children and adolescents under 18 years old, so it is preferable not to use this medication. In case of overdose, severe hypotension, heart problems, etc., medical attention should be sought immediately. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an opaque container to block light. It is also important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy.
White, round, film-coated rectangular tablets
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.